Abstract
32P-Postlabeling analysis is an ultrasensitive method for the detection and quantitation of DNA adducts and covalent modifications of the DNA. It consists of four main steps: (1) enzymatic digestion of DNA to 3′-monophosphate nucleosides; (2) enrichment of the adducts; (3) 5′OH-labeling of the adducts by T4 polynucleotide kinase-catalyzed transfer of 32P-orthophosphate from [γ-32P]ATP; and (4) chromatographic or electrophoretic separation of labeled adducts and detection and quantification by means of their radioactive decay. The assay requires only micrograms of DNA and is capable of detecting adduct levels as low as one adduct in 109–1010 normal nucleotides. It is applicable to a wide range of investigations in human, animal, and in vitro studies including monitoring exposure to environmental or occupational carcinogens, determining whether a chemical or a complex mixture has genotoxic properties, elucidation of the toxicological pathways of carcinogens, and monitoring DNA repair.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Phillips DH (2002) The formation of DNA adducts. In: Allison MR (ed) The cancer handbook. Macmillan, London, pp 293–306
Phillips DH, Arlt VM (2009) Genotoxicity: damage to DNA and its consequences. Exs 99:87–110
Phillips DH (2005) DNA adducts as markers of exposure and risk. Mutat Res 577:284–292
Luch A (2005) Nature and nurture—lessons from chemical carcinogenesis. Nat Rev Cancer 5:113–125
Arlt VM, Frei E, Schmeiser HH (2007) ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29–30 September 2006. Mutagenesis 22:83–88
Arlt VM, Schwerdtle T (2011) UKEMS/Dutch EMS-sponsored workshop on biomarkers of exposure and oxidative DNA damage & 7th GUM-32P-postlabelling workshop, University of Munster, Munster, Germany, 28–29 March 2011. Mutagenesis 26:679–685
Poirier MC, Santella RM, Weston A (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21:353–359
Brown K (2012) Methods for the detection of DNA adducts. In: Parry JM, Parry EM (eds) Genetic toxicology: principles and methods. Heidelberg, Humana, pp 207–230
Phillips DH, Arlt VM (2007) The 32P-postlabeling assay for DNA adducts. Nat Protoc 2:2772–2781
Randerath K, Reddy MV, Gupta RC (1981) 32P-labeling test for DNA damage. Proc Natl Acad Sci USA 78:6126–6129
Gupta RC, Reddy MV, Randerath K (1982) 32P-postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3:1081–1092
Reddy MV, Randerath K (1986) Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7:1543–1551
Gupta RC (1985) Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res 45:5656–5662
Randerath K, Randerath E, Danna TF et al (1989) A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5′-monophosphates. Carcinogenesis 10:1231–1239
Pfau W, Lecoq S, Hughes NC et al (1993) Separation of 32P-labelled 3′,5′-bisphosphate adducts by HPLC. In: Phillips DH, Castegnaro M, Bartsch H (eds) Postlabelling methods for detection of DNA adducts. IARC, Lyon, pp 233–242
Phillips DH, Hewer A, Horton MN et al (1999) N-Demethylation accompanies α-hydroxylation in the metabolic activation of tamoxifen in rat liver cells. Carcinogenesis 20:2003–2009
Nagy E, Cornelius MG, Moller L (2009) Accelerated (32)P-HPLC for bulky DNA adducts. Mutagenesis 24:183–189
Jones GD, Dickinson L, Lunec J et al (1999) SVPD—post-labeling detection of oxidative damage negates the problem of adventitious oxidative effects during 32P-labeling. Carcinogenesis 20:503–507
Phillips DH, Farmer PB, Beland FA et al (2000) Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ Mol Mutagen 35:222–233
Beland FA, Doerge DR, Churchwell MI et al (1999) Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem Res Toxicol 12:68–77
Haack T, Boche G, Kliem C et al (2004) Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3′-phosphate adducts. Chem Res Toxicol 17:776–784
Munnia A, Saletta F, Allione A et al (2007) 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies. Mutagenesis 22:381–385
Arlt VM, Stiborova M, Henderson CJ et al (2008) Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice. Carcinogenesis 29:656–665
Arlt VM, Zuo J, Trenz K et al (2011) Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Int J Cancer 128:21–32
Arlt VM (2005) 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence. Mutagenesis 20:399–410
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Schmeiser, H.H., Stiborova, M., Arlt, V.M. (2013). 32P-Postlabeling Analysis of DNA Adducts. In: Dhawan, A., Bajpayee, M. (eds) Genotoxicity Assessment. Methods in Molecular Biology, vol 1044. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-529-3_21
Download citation
DOI: https://doi.org/10.1007/978-1-62703-529-3_21
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-528-6
Online ISBN: 978-1-62703-529-3
eBook Packages: Springer Protocols